AusPAR: Bevacizumab

Australian Public Assessment Report

AusPAR

AusPAR: Bevacizumab [PDF, 549.59 KB]

AusPAR: Bevacizumab [Word, 875.71 KB]

Attachment: Product information for Bevacizumab [PDF, 512.39 KB]

Attachment: Product information for Bevacizumab [Word, 385.33 KB]

Device/Product Name

Abevmy

Active ingredients

Bevacizumab

AusPAR Date

28 January 2022

Published

2 February 2022

Submission Number

PM-2020-01736-1-4

Submission Type

New biosimilar medicine

Decision

Approved